These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 15809489)
1. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. Yagle KJ; Eary JF; Tait JF; Grierson JR; Link JM; Lewellen B; Gibson DF; Krohn KA J Nucl Med; 2005 Apr; 46(4):658-66. PubMed ID: 15809489 [TBL] [Abstract][Full Text] [Related]
2. Imaging apoptosis in vivo using 124I-annexin V and PET. Keen HG; Dekker BA; Disley L; Hastings D; Lyons S; Reader AJ; Ottewell P; Watson A; Zweit J Nucl Med Biol; 2005 May; 32(4):395-402. PubMed ID: 15878509 [TBL] [Abstract][Full Text] [Related]
3. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Murakami Y; Takamatsu H; Taki J; Tatsumi M; Noda A; Ichise R; Tait JF; Nishimura S Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):469-74. PubMed ID: 14666384 [TBL] [Abstract][Full Text] [Related]
4. Structural requirements for in vivo detection of cell death with 99mTc-annexin V. Tait JF; Smith C; Blankenberg FG J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355 [TBL] [Abstract][Full Text] [Related]
5. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET. Dekker B; Keen H; Lyons S; Disley L; Hastings D; Reader A; Ottewell P; Watson A; Zweit J Nucl Med Biol; 2005 Apr; 32(3):241-52. PubMed ID: 15820759 [TBL] [Abstract][Full Text] [Related]
6. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881 [TBL] [Abstract][Full Text] [Related]
8. Preliminary biological evaluation of ¹⁸F-FBEM-Cys-Annexin V a novel apoptosis imaging agent. Lu C; Jiang Q; Hu M; Tan C; Yu H; Hua Z Molecules; 2015 Mar; 20(3):4902-14. PubMed ID: 25789822 [TBL] [Abstract][Full Text] [Related]
10. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation. Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353 [TBL] [Abstract][Full Text] [Related]
11. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans. Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819 [TBL] [Abstract][Full Text] [Related]
12. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816 [TBL] [Abstract][Full Text] [Related]
13. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer. Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330 [TBL] [Abstract][Full Text] [Related]
14. Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124. Dekker B; Keen H; Shaw D; Disley L; Hastings D; Hadfield J; Reader A; Allan D; Julyan P; Watson A; Zweit J Nucl Med Biol; 2005 May; 32(4):403-13. PubMed ID: 15878510 [TBL] [Abstract][Full Text] [Related]
15. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. Tait JF; Smith C; Levashova Z; Patel B; Blankenberg FG; Vanderheyden JL J Nucl Med; 2006 Sep; 47(9):1546-53. PubMed ID: 16954565 [TBL] [Abstract][Full Text] [Related]
16. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. Ke S; Wen X; Wu QP; Wallace S; Charnsangavej C; Stachowiak AM; Stephens CL; Abbruzzese JL; Podoloff DA; Li C J Nucl Med; 2004 Jan; 45(1):108-15. PubMed ID: 14734682 [TBL] [Abstract][Full Text] [Related]
17. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. Taki J; Higuchi T; Kawashima A; Fukuoka M; Kayano D; Tait JF; Matsunari I; Nakajima K; Kinuya S; Strauss HW J Nucl Med; 2007 Aug; 48(8):1301-7. PubMed ID: 17631551 [TBL] [Abstract][Full Text] [Related]
18. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297 [TBL] [Abstract][Full Text] [Related]
20. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. Taki J; Higuchi T; Kawashima A; Tait JF; Kinuya S; Muramori A; Matsunari I; Nakajima K; Tonami N; Strauss HW J Nucl Med; 2004 Sep; 45(9):1536-41. PubMed ID: 15347721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]